The results showed that B-cells, cytolytic activity, mast cells, neutrophils, NK cells, T helper cells, Tumor-Infiltrating T Lymphocytes (TIL), Type II interferon responses (Type II IFN Response, IFN-γ) in the low-risk group were significantly higher than those in the high-risk group (Fig. 5C), which suggested an impaired anti-tumor immune function in the high-risk group. This evidence concerns the gene IFNG and neoplasm.